Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy
- 1 May 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 32 (5) , 1052-1056
- https://doi.org/10.1021/jm00125a020
Abstract
Generally, antipsychotic agents are dopamine receptor blocking agents that also block conditioned avoidance responding (CAR) in the rat. Recently, however, both (o-methoxyphenyl)piperazine (OMPP, 1h) and (m-chlorophenyl)piperazine (MCPP), 1o) have been reported to block conditioned avoidance responding in the rat although neither has dopamine receptor blocking properties. The present paper examines the behavioral and biochemical profile of a number of additional substituted phenylpiperazines. None of the phenylpiperazines tested demonstrated high affinity for either dopamine D-1 or D-2 receptor sites, yet many were effective in blocking CAR. The results suggest that the phenylpiperazines may be effective antipsychotic agents without blocking dopamine receptors. Moreover, the active compounds did demonstrate activity in displacing ligand binding to serotonin receptors. Receptor binding profiles were determined for 5-HT-1A and 5-HT-1B binding sites as well as for 5-HT-2 sites. The data from this preclinical test suggest these phenylpiperaines might be effective antipsychotic agents acting via a nondopaminergic mechanism of action.Keywords
This publication has 4 references indexed in Scilit:
- PRECLINICAL EVALUATION OF MCN-5707 AS A POTENTIAL ANTIDEPRESSANT1987
- Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical dosesPharmacology Biochemistry and Behavior, 1981
- Central serotonin-like activity of 6-chloro-2-[1-piperazinyl]-pyrazine (CPP; MK-212)European Journal of Pharmacology, 1977
- Synthesis and Pharmacological Study of New Piperazine Derivatives. II. PhenethylpiperazinesJournal of Medicinal Chemistry, 1965